Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 16, 2015

View Archived Issues

Nucleic acid antibody prophylaxis as an antiviral immunotherapy for dengue

FDA OOPD awards grant to support development of ADXS-HPV in throat cancer

PeptiDream and Sanofi establish peptide discovery collaboration

RaQualia selects RQ-00433412 for preclinical development in cancer cachexia

STAT2 regulates mitochondrial fission

Baxalta files for U.S. approval of 20% immunoglobulin subcutaneous

XenoPort reports phase II study data for XP-23829

P2X7R antagonist reduces neuronal death in epilepsy model

Amicus Therapeutics to submit NDA for migalastat for Fabry disease

Teijin Pharma and Amgen report ROR-gamma antagonists

BARDA funding awarded to Crucell Holland to accelerate Ebola vaccine program

Laboratoire Biodim discloses dltA inhibitors

Glenmark Pharmaceuticals' GBR-1302 to enter phase I trials

Ono Pharmaceutical describes EP2 agonists

Jiangsu Ascentage Biomed Development reports ALK inhibitors

Andexanet alfa achieves rapid and sustained reversal of rivaroxaban in phase III trial

Sichuan Haisco Pharmaceutical reports phosphoramidate antivirals

Mylan initiates offer for Perrigo shares, Perrigo tells shareholders to wait

RepliCel starts phase I trial of autologous fibroblast therapy RCS-01

AZTherapies initiates phase III study of ALZT-OP1 for early Alzheimer's disease

Seegene and BD Life Sciences collaborate to develop multiplex molecular diagnostic assays

Bionomics reports data from phase I trial of BNC-210 for anxiety and depression

Depomed urges shareholders to reject Horizon Pharma's unsolicited exchange offer

Hemostemix signs strategic alliance agreement with Hemostemix Asia for ACP-01

Cotranstplantation of islets and dental pulp stem cells improves survival in diabetic mice

ALCAM mediates late kidney complications of diabetes

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026